HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR NANOGRAM DETERMINATION OF CHLORPROMAZINE AND ITS COMPARISON WITH A RADIOIMMUNOASSAY

被引:38
作者
MIDHA, KK
COOPER, JK
MCGILVERAY, IJ
BUTTERFIELD, AG
HUBBARD, JW
机构
[1] UNIV SASKATCHEWAN, COLL PFLANZENPHYSIOL, SASKATOON S7N 0W0, SASKATCHEWAN, CANADA
[2] HLTH & WELF CANADA, HLTH PROTECT BRANCH, DRUG RES LABS, OTTAWA K1A 0L2, ONTARIO, CANADA
[3] UNIV MANITOBA, FAC PFLANZENPHYSIOL, WINNIPEG R3T 2N2, MANITOBA, CANADA
关键词
D O I
10.1002/jps.2600700920
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[Chlorpromazine is widely used in the treatment of certain psychiatric disorders.] A specific and sensitive high-performance liquid chromatographic (HPLC) method for the quantitative determination of [human] plasma chlorpromazine concentrations is described. The procedure is capable of determining 1 ng of chlorpromazine/ml and is adequate for following plasma concentration-time profiles after 7 mg single i.v. doses. After a single organic extraction of the drug and an internal standard (mesoridazine) from plasma, the organic layer was transferred to a vial and evaporated to dryness at 55.degree. under N. The residue was dissolved in 200 .mu.l of HPLC grade acetonitrile. Aliquots (70-100 .mu.l) were chromatographed and the drug was quantitated in the range of 1-15 ng/ml of plasma using a fixed-wavelength UV detector. Plasma concentrations determined by the method were compared with those obtained by a previously reported radioimmunoassay specific for chlorpromazine and N-desmethylchlorpromazine. The 2 methods agreed favorably with a correlation coefficient of 0.993 and a slope of 0.994.
引用
收藏
页码:1043 / 1046
页数:4
相关论文
共 19 条
[1]   MASS FRAGMENTOGRAPHIC METHOD FOR DETERMINATION OF CHLORPROMAZINE AND 2 OF ITS ACTIVE METABOLITES IN HUMAN-PLASMA AND CSF [J].
ALFREDSSON, G ;
WODEHELGODT, B ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1976, 48 (02) :123-131
[2]  
CURRY SH, 1976, PSYCHOPHARMACOL COMM, V2, P1
[3]   RADIOASSAY OF CHLORPROMAZINE AND ITS METABOLITES IN PLASMA [J].
EFRON, DH ;
HARRIS, SR ;
MANIAN, AA ;
GAUDETTE, LE .
PSYCHOPHARMACOLOGIA, 1971, 19 (03) :207-&
[4]  
FORREST IS, 1970, AGRESSOLOGIE, V11, P127
[5]  
FORREST IS, 1976, P W PHARMACOL SOC, V19, P125
[6]  
FORREST IS, 1978, COMMUN PSYCHOPHARMAC, V2, P131
[7]   MASS FRAGMENTOGRAPHY - IDENTIFICATION OF CHLORPROMAZINE AND ITS METABOLITIES IN HUMAN BLOOD BY A NEW METHOD [J].
HAMMAR, CG ;
HOLMSTEDT, B ;
RYHAGE, R .
ANALYTICAL BIOCHEMISTRY, 1968, 25 (1-3) :532-+
[8]   RADIOIMMUNOASSAY FOR PSYCHOTROPIC-DRUGS .1. SYNTHESIS AND PROPERTIES OF HAPTENS FOR CHLORPROMAZINE [J].
HUBBARD, JW ;
MIDHA, KK ;
MCGILVERAY, IJ ;
COOPER, JK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) :1563-1571
[9]   CHLORPROMAZINE METABOLISM .7. NEW QUANTITATIVE FLUOROMETRIC-DETERMINATION OF CHLORPROMAZINE AND ITS SULFOXIDE [J].
KAUL, PN ;
WHITFIELD, LR ;
CLARK, ML .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (05) :689-694
[10]  
KAUL PN, 1974, PHENOTHIAZINES STRUC, P391